https://www.selleckchem.com/products/ibmx.html
ics, including level, severity and chronicity. The authors' present protocol demonstrates that intrathecal administration of' allogeneic hUC-MSCs at a dose of 10 cells/kg once a month for 4 months is safe and effective and leads to significant improvement in neurological dysfunction and recovery of quality of life. The authors' present protocol demonstrates that intrathecal administration of' allogeneic hUC-MSCs at a dose of 106 cells/kg once a month for 4 months is safe and effective and leads to significant improvement in neurological dy
Like
Comment
Share
